These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1900094)

  • 1. Thermoregulatory and endocrine effects of a low dose of danazol in postmenopausal women: interaction with the effect of naloxone.
    Cagnacci A; Melis GB; Paoletti AM; Soldani R; Fioretti P
    Life Sci; 1991; 48(11):1051-8. PubMed ID: 1900094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of transdermal 17 beta-estradiol treatment and naloxone infusion on gonadotropin response to gonadotropin-releasing hormone in postmenopausal women.
    Cagnacci A; Melis GB; Paoletti AM; Soldani R; Fioretti P
    J Clin Endocrinol Metab; 1990 Feb; 70(2):365-70. PubMed ID: 2105330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of danazol on pituitary function and on the ovarian follicular hormone secretion in premenopausal women.
    Rannevik G; Thorell JI
    Acta Obstet Gynecol Scand Suppl; 1984; 123():89-94. PubMed ID: 6437127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease.
    Cagnacci A; Melis GB; Soldani R; Bonuccelli U; Piccini P; Napolitano A; Muratorio A; Fioretti P
    Neuroendocrinology; 1991 Jun; 53(6):549-55. PubMed ID: 1678880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of danazol on anterior pituitary function.
    Franchimont P; Cramilion C
    Fertil Steril; 1977 Aug; 28(8):814-7. PubMed ID: 407104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol effects on naloxone-stimulated luteinizing hormone, follicle-stimulating hormone and prolactin plasma levels in female rhesus monkeys.
    Mello NK; Mendelson JH; Bree MP; Skupny A
    J Pharmacol Exp Ther; 1988 Jun; 245(3):895-904. PubMed ID: 3133465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis.
    Lanfranco F; Bonelli L; Baldi M; Me E; Broglio F; Ghigo E
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3633-9. PubMed ID: 18559917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women.
    Bondanelli M; Ambrosio MR; Franceschetti P; Guerrini R; Valentini A; degli Uberti EC
    Hum Reprod; 1998 May; 13(5):1159-62. PubMed ID: 9647539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sex steroids on body temperature in postmenopausal women. Role of endogenous opioids.
    Cagnacci A; Melis GB; Soldani R; Paoletti AM; Fioretti P
    Life Sci; 1992; 50(7):515-21. PubMed ID: 1311794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of danazol on serum concentrations of pituitary gonadotropins in postmenopausal women.
    Döberl A; Jeppsson S; Rannevik G
    Acta Obstet Gynecol Scand Suppl; 1984; 123():95-8. PubMed ID: 6437128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periovulatory plasma prolactin response to gonadotropin-releasing hormone: role of endogenous opiates.
    De Marinis L; Mancini A; D'Amico C; Calabró F; Zuppi P; Fiumara C; Barini A
    Neuroendocrinology; 1990 Jun; 51(6):717-20. PubMed ID: 2114008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine.
    Petraglia F; Porro C; Facchinetti F; Cicoli C; Bertellini E; Volpe A; Barbieri GC; Genazzani AR
    Life Sci; 1986 Jun; 38(23):2103-10. PubMed ID: 3086650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that estrogens inhibit LH secretion through opioids in postmenopausal women using naloxone.
    Melis GB; Paoletti AM; Gambacciani M; Mais V; Fioretti P
    Neuroendocrinology; 1984 Jul; 39(1):60-3. PubMed ID: 6087184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women.
    Couzinet B; Young J; Kujas M; Meduri G; Brailly S; Thomas JL; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4191-6. PubMed ID: 10566671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrogation by a potent gonadotropin-releasing hormone antagonist of the estrogen/progesterone-stimulated surge-like release of luteinizing hormone and follicle-stimulating hormone in postmenopausal women.
    Kolp LA; Pavlou SN; Urban RJ; Rivier JC; Vale WW; Veldhuis JD
    J Clin Endocrinol Metab; 1992 Oct; 75(4):993-7. PubMed ID: 1400893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Danazol: endocrine consequences in healthy women.
    Luciano AA; Hauser KS; Chapler FK; Sherman BM
    Am J Obstet Gynecol; 1981 Nov; 141(6):723-7. PubMed ID: 6797301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.